中华结核和呼吸杂志
中華結覈和呼吸雜誌
중화결핵화호흡잡지
Chinese Journal of Tuberculosis and Respiratory Diseases
2014年
7期
512-516
,共5页
桂静%李金莉%洪创跃%王峰
桂靜%李金莉%洪創躍%王峰
계정%리금리%홍창약%왕봉
分枝杆菌属%热休克蛋白质类%克拉霉素%诱导耐药
分枝桿菌屬%熱休剋蛋白質類%剋拉黴素%誘導耐藥
분지간균속%열휴극단백질류%극랍매소%유도내약
Mycobacterium%Heat-hock proteins%Clarithromycin%Inducible resistance
目的 研究脓肿分枝杆菌复合群亚种鉴定的有效方法.方法 将19株克拉霉素敏感的脓肿分枝杆菌临床分离株扩增hsp65和rpoB基因相关序列,分别用Mega软件和PhyML软件单独及联合对其构建系统进化树以鉴定其亚种,对鉴定结果不一致的菌株进行16S-23S间隔序列测序加以判定.扩增分析rrl和erm(41)基因特征,采用微量肉汤稀释法对菌株进行克拉霉素诱导耐药检测,分析各亚种的基因表型模式.结果 19株脓肿分枝杆菌复合群中,hsp65和rpoB基因鉴定结果一致的有Mycobacterium massiliense(M.massiliense)亚种10株、Mycobacterium abscessus(M.abscessus)亚种4株和Mycobacterium bolletii(M.bolletii亚种1株,其余4株采用hsp65基因分类为M.massiliense,采用rpoB基因分类为M.abscessus,最终采用间隔序列测序鉴定为M.massiliense.rrl基因分析19株均未发现与克拉霉素耐药相关的突变.erm(41)基因分析结果表明,M.abscessus的-35位启动子序列与M.bolletii和M.massiliense不同,第28位碱基存在多态性(T28或C28),M.bolletii和M.massiliense的-35位启动子序列及第28位碱基分子特征一致.14株M.massiliense菌株均存在erm(41)基因276 bp长片段和2 bp短片段缺失,4株M.abscessus和1株M.bolletii均携带完整的erm (41)基因.克拉霉素诱导耐药试验结果显示,3株携带T28的M.abscessus(菌株号:CI02、CI04和CI12)和1株M.bolletii均可诱导产生克拉霉素高水平耐药,其余14株M.massiliense和1株携带C28多态性的M.abscessus(菌株号:CI17)对克拉霉素始终保持敏感.暂未发现-35位启动子序列差异与克拉霉素诱导耐药相关.结论 hsp65基因适用于脓肿分枝杆菌复合群亚种分子鉴定,且脓肿分枝杆菌复合群的erm(41)基因分子特征及相关克拉霉素诱导耐药表型特征均有亚种特异性,hsp65基因和erm(41)基因检测可用于脓肿分枝杆菌复合群亚种鉴定.
目的 研究膿腫分枝桿菌複閤群亞種鑒定的有效方法.方法 將19株剋拉黴素敏感的膿腫分枝桿菌臨床分離株擴增hsp65和rpoB基因相關序列,分彆用Mega軟件和PhyML軟件單獨及聯閤對其構建繫統進化樹以鑒定其亞種,對鑒定結果不一緻的菌株進行16S-23S間隔序列測序加以判定.擴增分析rrl和erm(41)基因特徵,採用微量肉湯稀釋法對菌株進行剋拉黴素誘導耐藥檢測,分析各亞種的基因錶型模式.結果 19株膿腫分枝桿菌複閤群中,hsp65和rpoB基因鑒定結果一緻的有Mycobacterium massiliense(M.massiliense)亞種10株、Mycobacterium abscessus(M.abscessus)亞種4株和Mycobacterium bolletii(M.bolletii亞種1株,其餘4株採用hsp65基因分類為M.massiliense,採用rpoB基因分類為M.abscessus,最終採用間隔序列測序鑒定為M.massiliense.rrl基因分析19株均未髮現與剋拉黴素耐藥相關的突變.erm(41)基因分析結果錶明,M.abscessus的-35位啟動子序列與M.bolletii和M.massiliense不同,第28位堿基存在多態性(T28或C28),M.bolletii和M.massiliense的-35位啟動子序列及第28位堿基分子特徵一緻.14株M.massiliense菌株均存在erm(41)基因276 bp長片段和2 bp短片段缺失,4株M.abscessus和1株M.bolletii均攜帶完整的erm (41)基因.剋拉黴素誘導耐藥試驗結果顯示,3株攜帶T28的M.abscessus(菌株號:CI02、CI04和CI12)和1株M.bolletii均可誘導產生剋拉黴素高水平耐藥,其餘14株M.massiliense和1株攜帶C28多態性的M.abscessus(菌株號:CI17)對剋拉黴素始終保持敏感.暫未髮現-35位啟動子序列差異與剋拉黴素誘導耐藥相關.結論 hsp65基因適用于膿腫分枝桿菌複閤群亞種分子鑒定,且膿腫分枝桿菌複閤群的erm(41)基因分子特徵及相關剋拉黴素誘導耐藥錶型特徵均有亞種特異性,hsp65基因和erm(41)基因檢測可用于膿腫分枝桿菌複閤群亞種鑒定.
목적 연구농종분지간균복합군아충감정적유효방법.방법 장19주극랍매소민감적농종분지간균림상분리주확증hsp65화rpoB기인상관서렬,분별용Mega연건화PhyML연건단독급연합대기구건계통진화수이감정기아충,대감정결과불일치적균주진행16S-23S간격서렬측서가이판정.확증분석rrl화erm(41)기인특정,채용미량육탕희석법대균주진행극랍매소유도내약검측,분석각아충적기인표형모식.결과 19주농종분지간균복합군중,hsp65화rpoB기인감정결과일치적유Mycobacterium massiliense(M.massiliense)아충10주、Mycobacterium abscessus(M.abscessus)아충4주화Mycobacterium bolletii(M.bolletii아충1주,기여4주채용hsp65기인분류위M.massiliense,채용rpoB기인분류위M.abscessus,최종채용간격서렬측서감정위M.massiliense.rrl기인분석19주균미발현여극랍매소내약상관적돌변.erm(41)기인분석결과표명,M.abscessus적-35위계동자서렬여M.bolletii화M.massiliense불동,제28위감기존재다태성(T28혹C28),M.bolletii화M.massiliense적-35위계동자서렬급제28위감기분자특정일치.14주M.massiliense균주균존재erm(41)기인276 bp장편단화2 bp단편단결실,4주M.abscessus화1주M.bolletii균휴대완정적erm (41)기인.극랍매소유도내약시험결과현시,3주휴대T28적M.abscessus(균주호:CI02、CI04화CI12)화1주M.bolletii균가유도산생극랍매소고수평내약,기여14주M.massiliense화1주휴대C28다태성적M.abscessus(균주호:CI17)대극랍매소시종보지민감.잠미발현-35위계동자서렬차이여극랍매소유도내약상관.결론 hsp65기인괄용우농종분지간균복합군아충분자감정,차농종분지간균복합군적erm(41)기인분자특정급상관극랍매소유도내약표형특정균유아충특이성,hsp65기인화erm(41)기인검측가용우농종분지간균복합군아충감정.
Objective To identify the subspecies of Mycobacterium abscessus (M.abscessus) group.Methods The corresponding genes (hsp65 and rpoB) in 19 clinical isolates (CIs) of M.abscessus group susceptible to clarithromycin were amplified by PCR.Phylogenetic analyses and subspecies identification of the hsp65 gene and rpoB gene were conducted separately and jointly by using the Mega program and PhyML program,and the conflicting species were further identified by the internally transcribed spacer (ITS) sequencing.The rrl and erm(41) of M.abscessus group detection were performed by PCR sequencing,and MICs of inducible resistance to clarithromycin were determined by the broth microdilution method,and then the phenotypic patterns of 19 isolates were analyzed.Results Comparisons between hsp65 and rpoB sequences of the 19 clinical isolates led to the identification of 10 CIs as Mycobacterium (M).massiliense,4 CIs as Mycobacterium (M).abscessus,and 1 CI as Mycobacterium (M).bolletii,while the other 4 isolates were identified as M.massiliense by hsp65 gene sequencing and as M.abscessus by rpoB gene sequencing.Ultimately the 4 conflicting isolates were identified as M.massiliense by ITS sequencing.Nomutations in the rrl gene with clarithromycin resistance were found.The-35 sequence of the erm (41)promoter of M.abscessus was different from that of M.bolletii and M.massiliense,and the nucleotide at position 28 was polymorphic (T28 or C28) ;-35 sequence and the nucleotide at position 28 were the same in erm(41) for M.bolletii and M.massiliense.Fourteen M.massiliense strains shared 100% (14/14) homology for erm(41) with 276 bp deletions and 2 bp deletions,and no deletions were found in 4 CIs as M.abscessus and 1 CIs as M.bolletii.The elarithromyein inducible resistance test showed that 3 M.abscessus with T28 (CI02,CI04,CI12) and 1 M.bolletii (CI18) strains were highly resistant,and the other 14 M.massiliense and 1 M.abscessus with polymorphic C28 (CI17) strains remained susceptible.No correlations between-35 sequence of erm(41) promoter and clarithromycin inducible resistance were found.Conclusions Hsp65 is applicable to the identification of the subspecies of M.abscessus group,and due to the fact that subspecies of M.abscessus group shows distinct genotytpcally feature in erm(41) sequencing and phenotypic feature in clarithromycin susceptibility,hsp65 and erm(41) can be applied to the identification of subspecies of M.abscessus group,and the resulting data may be useful for clinical diagnosis and treatments.